MedTrace Logo

The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses

NCT00786994 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2015-09-14

Study results available
· View outcomes & findings →

Summary

In this study the impact of Oleogel-S-10 versus placebo on actinic keratoses over a treatment period of 3 months will be tested. Additionally, once and twice daily applications are tested.

Conditions

  • Actinic Keratoses

Interventions

DRUG

Oleogel-S10 100 mg/g

topical use once or twice daily

DRUG

Placebo (petroleum jelly)

topical use once or twice daily

Sponsors & Collaborators

  • University Hospital Tuebingen

    collaborator OTHER

  • Birken AG

    lead INDUSTRY

Principal Investigators

  • Claus Garbe, Prof. Dr. · Universitätshautklinik Tübingen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Germany
  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00786994 on ClinicalTrials.gov